Literature DB >> 22994218

The ischemic penumbra: how does tissue injury evolve?

Wolf-Dieter Heiss1.   

Abstract

An ischemic penumbra has the potential for functional recovery provided that local blood flow can be reestablished, but irreversible damage will develop without sufficient reperfusion, depending on the interaction of severity and duration of ischemia. With acute flows below the threshold required for maintenance of basic housekeeping, injury in the core is established within a few minutes. During the subacute phase, the irreversible damage expands into the penumbra: multiple electrical and biological signals are triggered by periinfarct, spreading depression-like depolarizations leading to hypoxia and stepwise increase in lactate. Usually within 6 to 8 hours, all the penumbra are converted into irreversible infarcts. In a delayed phase, secondary phenomena may cause additional tissue damage: disruption of the tight junctions results in vasogenic edema, leading to increase of water content and damage expansion. Neutrophils and cytokinins cause secondary inflammation, inducing further damage in periinfarct regions and connecting fiber tracts. Multimodal imaging might be able to differentiate among the tissue compartments affected by acute, subacute, or delayed ischemic damage, and thereby might provide the basis for phase-specific treatment strategies.
© 2012 New York Academy of Sciences.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22994218     DOI: 10.1111/j.1749-6632.2012.06668.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  50 in total

1.  Pressure modulation algorithm to separate cerebral hemodynamic signals from extracerebral artifacts.

Authors:  Wesley B Baker; Ashwin B Parthasarathy; Tiffany S Ko; David R Busch; Kenneth Abramson; Shih-Yu Tzeng; Rickson C Mesquita; Turgut Durduran; Joel H Greenberg; David K Kung; Arjun G Yodh
Journal:  Neurophotonics       Date:  2015-08-04       Impact factor: 3.593

2.  Materials to Promote Recovery After Stroke.

Authors:  Kevin Erning; Tatiana Segura
Journal:  Curr Opin Biomed Eng       Date:  2020-04-13

3.  Blood cells and endothelial barrier function.

Authors:  Stephen F Rodrigues; D Neil Granger
Journal:  Tissue Barriers       Date:  2015-04-03

4.  Stroke-induced brain parenchymal injury drives blood-brain barrier early leakage kinetics: a combined in vivo/in vitro study.

Authors:  Mélanie Kuntz; Caroline Mysiorek; Olivier Pétrault; Maud Pétrault; Rustem Uzbekov; Régis Bordet; Laurence Fenart; Roméo Cecchelli; Vincent Bérézowski
Journal:  J Cereb Blood Flow Metab       Date:  2013-10-02       Impact factor: 6.200

5.  Endotoxemia induces lung-brain coupling and multi-organ injury following cerebral ischemia-reperfusion.

Authors:  Nguyen Mai; Landa Prifti; Aric Rininger; Hannah Bazarian; Marc W Halterman
Journal:  Exp Neurol       Date:  2017-07-28       Impact factor: 5.330

6.  Dynamic changes in sleep-related breathing abnormalities in bilateral paramedian mesencephalon and thalamus stroke: a follow-up case study.

Authors:  Béla Faludi; Márton Tóth; Gabriella Pusch; Sámuel Komoly
Journal:  Sleep Breath       Date:  2015-06-13       Impact factor: 2.816

7.  GLP-1R activation for the treatment of stroke: updating and future perspectives.

Authors:  Vladimer Darsalia; David Nathanson; Thomas Nyström; Thomas Klein; Åke Sjöholm; Cesare Patrone
Journal:  Rev Endocr Metab Disord       Date:  2014-09       Impact factor: 6.514

Review 8.  Endovascular Stroke Therapy.

Authors:  Wade S Smith
Journal:  Neurotherapeutics       Date:  2019-04       Impact factor: 7.620

Review 9.  Motor System Reorganization After Stroke: Stimulating and Training Toward Perfection.

Authors:  Theresa A Jones; DeAnna L Adkins
Journal:  Physiology (Bethesda)       Date:  2015-09

Review 10.  Involvement of extrasynaptic glutamate in physiological and pathophysiological changes of neuronal excitability.

Authors:  Balázs Pál
Journal:  Cell Mol Life Sci       Date:  2018-05-15       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.